Abstract
Paraplegic patients have intractable constipation associated with prolonged colonic transit time. The agent Cisapride significantly reduced the colonic transit time from 7.7 days to 5.1 days. It also improved the intraluminal tone in the rectum, resulting in a significant reduction in maximal rectal capacity from 305.8 ml to 224.3 ml. There was a reduction in residual urine volume from 51.5 ml to 27.7 ml. The increased number of stools containing transit markers showed that intraluminal mixing was increased by cisapride. Faecal water remained unchanged. A side effect was retention of urine in one subject after sudden withdrawal of the drug but this was avoided by its gradual reduction over 2 days.
Similar content being viewed by others
Article PDF
References
Bayliss W M, Starling E N 1900 The mass movements and the innervation of the large intestine. Journal of Physiology 26: 107–118.
Bond J H, Levitt M D 1975 Investigation of small bowel transit time in man utilizing pulmonary hydrogen measurements. Journal of Laboratory and Clinical Medicine 85: 546–555.
Christensen J 1981 Motility of the Colon. Chapter 14. Physiology of the Gastrointestinal Tract, Ed. Johnson LR. Raven Press, New York.
Connell A M, Frankel H L, Guttmann L 1963 The motility of the pelvic colon following complete lesions of the spinal cord. Paraplegia 1: 93–115.
Corazziari E, Bontempo I, Anzi F, et al. 1985 Effect of cisapride on esophageal motor activity before and after atropine administration. Gastroenterology 88: 1355.
Denny-Brown D, Robertson G 1935 An investigation of the nervous control of defecation. Brain 58: 256–310
Eastwood M A, Brydon W G et al. 1984 Faecal weight and composition, serum lipids, and diet among subjects aged 18 to 80 years not seeking health care. American Journal of Clinical Nutrition 40: 628–634.
Edwards C A, Holden S, Brown C, et al. 1987 Effect of cisapride on the gastrointestinal transit of solid meal in normal human subjects. Gut 28: 13–16.
Glick M E, Meshkinapour H et al. 1984 Colonic dysfunction in patients with thoracic spinal cord injury. Gastroenterology 86: 287–294.
Gowers W R 1877 The automatic action of the sphincter ani. Proceedings of the Royal Society London 26: 77–84.
Henry M M, Snooks S J et al. 1985 Investigation of disorders of the anorectum and colon. Annals R Col. Surg. Eng. 67: 355–360.
Hinton J M, Lennard-Jones J E, Young A C 1969. A new method for measuring gut transit using radio-opaque markers. Gut 10: 842: 7.
Jian R, Ducrot F, Piedeloup C, et al. 1985 Measurement of gastric emptying in dyspeptic patients: effect of a new gastrokinetic agent (cisapride). Gut 26: 352–358.
Koop H, Monnikes H et al. 1986 Effect of the prokinetic drug cisapride on gastrointestinal hormone release. Scandinavian Journal of Gastroenter ology 21: 907–1013.
Lederer P C, Ellerman A, Schmidt H, et al. 1985 Effect of cisapride on sigmoid motility in healthy subjects and in diabetic enteropathy (DE) with constipation. 1985. Gastroenterology 88: 1468.
Lee K Y, Chey W Y, You C H, et al. 1984 Effect of cisapride on the motility of gut in dogs and colonic transit time in dogs and humans. Gastroenter ology 86: 1157.
Lehmkull L D, Dimitrijevic M R, Zidar J 1986 Lumbosacral evoked potentials (LSEP) and cortical somatosensory evoked potentials (SEP) in patients with a cauda equina lesion. Paraplegia 24: 46.
Miller-Lissner S A 1985 Cisapride in chronic constipation and laxative abuse. Gastroenterology 88: 1510.
Moriarty K J, Higgs N B, Woodford M, et al. 1985 Cisapride inhibits the secretory action of serotonin (5-HT) in mammalian small intestine. Gut 26: A 1111.
Smith A N, Varma J S 1984 The latency of the pudendo-anal reflex in man. Journal of Physiology 360: 49P.
Smout A J PM, Bogaard J W, Grade A C, et al. 1985 Effects of cisapride, a new gastrointestinal prokinetic substance, on interdigestive and postprandial motor activity of the distal oesophagus in man. Gut 26: 246–251.
Snape W J . Clarke D D, Gautsch E 1985 Effect of cisapride on colonic smooth muscle in vivo and in vitro. Gastroenterology 88: 1592.
Stacher G, Steinringer H, Schneider C, et al. 1986 Effects of cisapride on jejunal motor activity in fasting healthy humans. Gastroenterology 90: 1210–1216.
Thomforde G M, Zinsmeister A R, Brown M L, et al. 1985 Effects of cisapride (cis) and metoclopramide (met) on fed gastrointestinal motility and transit in a chronic dog model. Gastroenterology 88: 1613.
Varma J S, Smith A N 1986 Reproducibility of the proctometrogram. Gut 27: 288–292.
Varma J S, Binnie N et al. 1986 Differential effects of sacral anterior root stimulation on anal sphincter and colorectal motility in spinally injured man. British Journal of Surgery 73: 478–482.
Varma J S, Smith A N 1984 Anorectal profilometry with the microtransducer. British Journal of Surgery 71: 867–869.
Van Nueten J M, Leysen J E, Niemegeers C J E, et al. 1985 Cholinergic vs anti-dopaminergic properties of prokinetic substituted benzamides with gastrointestinal prokinetic activity. Gastroenterology 88: 1623.
Wienbeck M, Cuder-Wiesinger E, Berges W 1984 Cisapride acts as a motor stimulator in the human oesophagus. Gastroenterology 85: 1298.
Wood J D, 1981 Physiology of the Enteric Nervous System. Chapter 1. Physiology of the Gastrointestinal Tract, Ed. Johnson LR. Raven Press, New York.
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Binnie, N., Creasey, G., Edmond, P. et al. The action of Cisapride on the chronic constipation of paraplegia. Spinal Cord 26, 151–158 (1988). https://doi.org/10.1038/sc.1988.24
Issue Date:
DOI: https://doi.org/10.1038/sc.1988.24